| Drug name |
Drug type |
Disease/phenotype |
Mechanism of action(MoA) |
Phase |
Status |
Source |
| ISTAROXIME | Small molecule | heart failure | Sodium/potassium-transporting ATPase inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| ISTAROXIME | Small molecule | heart failure | Sodium/potassium-transporting ATPase inhibitor | 2.0 | Completed | ClinicalTrials |
| ISTAROXIME | Small molecule | Shock | Sodium/potassium-transporting ATPase inhibitor | 2.0 | Recruiting | ClinicalTrials |
| ISTAROXIME | Small molecule | congestive heart failure | Sodium/potassium-transporting ATPase inhibitor | 0.5 | Completed | ClinicalTrials |
| ISTAROXIME | Small molecule | heart failure | Sodium/potassium-transporting ATPase inhibitor | 2.0 | Unknown status | ClinicalTrials |
| ISTAROXIME | Small molecule | heart failure | Sodium/potassium-transporting ATPase inhibitor | 1.0 | Withdrawn | ClinicalTrials |